Daxor announces cooperative research and development phase ii agreement with the uniformed armed services university for the development of a non-nuclear blood volume analysis (bva) device

New bva device aims to possess gold standard accuracy and reproducibility with increased safety, access, ease of use, and frequency of testing afforded by a non-nuclear tracer

DXR Ratings Summary

DXR Quant Ranking